Abstract:Insulin fibrillation provides a model for a broad class of amyloidogenic diseases. Conformational distortion of the native monomer leads to aggregation-coupled misfolding. Whereas beta-cells are protected from proteotoxicity by hexamer assembly, fibrillation limits the storage and use of insulin at elevated temperatures. Here, we have investigated conformational distortions of an engineered insulin monomer in relation to the structure of an insulin fibril. Anomalous (13)C NMR chemical shifts and rapid (15)N-detected (1)H-(2)H amide-proton exchange were observed in one of the three classical alpha-helices (residues A1-A8) of the hormone, suggesting a conformational equilibrium between locally folded and unfolded A-chain segments. Whereas hexamer assembly resolves these anomalies in accordance with its protective role, solid-state (13)C NMR studies suggest that the A-chain segment participates in a fibril-specific beta-sheet. Accordingly, we investigated whether helicogenic substitutions in the A1-A8 segment might delay fibrillation. Simultaneous substitution of three beta-branched residues (Ile(A2) --> Leu, Val(A3) --> Leu, and Thr(A8) --> His) yielded an analog with reduced thermodynamic stability but marked resistance to fibrillation. Whereas amide-proton exchange in the A1-A8 segment remained rapid, (13)Calpha chemical shifts exhibited a more helical pattern. This analog is essentially without activity, however, as Ile(A2) and Val(A3) define conserved receptor contacts. To obtain active analogs, substitutions were restricted to A8. These analogs exhibit high receptor-binding affinity; representative potency in a rodent model of diabetes mellitus was similar to wild-type insulin. Although (13)Calpha chemical shifts remain anomalous, significant protection from fibrillation is retained. Together, our studies define an "Achilles' heel" in a globular protein whose repair may enhance the stability of pharmaceutical formulations and broaden their therapeutic deployment in the developing world.

Monitoring and Inhibition of Insulin Fibrillation by a Small Organic Fluorogen with Aggregation-Induced Emission Characteristics.

Dual Functional Amphiphilic Sugar-Coated AIE-active Fluorescent Organic Nanoparticles for the Monitoring and Inhibition of Insulin Amyloid Fibrillation Based on Carbohydrate-Protein Interactions.

Monitoring and Modulation of Insulin Fibers by a Protein Isomerization Targeting Dye Bromophenol Blue

Target-triggered and Controlled Release Plasmon-Enhanced Fluorescent AIE Probe for Conformational Monitoring of Insulin Fibrillation.

Cationic molecular probes based on aggregation-induced emission for fluorescent sensing and super-resolution imaging of insulin fibrosis

Fluorescent Silicon Nanoparticles Inhibit the Amyloid Fibrillation of Insulin

Fluorimetric Detection of Insulin Misfolding by Probes Derived from Functionalized Fluorene Frameworks

Nontoxic Black Phosphorus Quantum Dots Inhibit Insulin Amyloid Fibrillation at an Ultralow Concentration

A Small Molecule Impedes Insulin Fibrillation: Another New Role of Phenothiazine Derivatives

High resolution spectroscopy reveals fibrillation inhibition pathways of insulin

Quinoline yellow acts as a novel amyloid fibrillation probe by using surface-enhanced Raman spectroscopy

Ferrocene-modified peptides as inhibitors against insulin amyloid aggregation based on molecular simulation.

Inhibition of amyloidal aggregation of insulin by amino acid conjugated bile acids: An insight into the possible role of biosurfactants in modulating the fibrillation kinetics and cytotoxicity

Photo-induced Inhibition of Insulin Amyloid Fibrillation on Online Laser Measurement.

Efficient Encapsulation of Insulin by Giant Macrocycle as a Powerful Approach to the Inhibition of Its Fibrillation

In Vivo and in Vitro Monitoring of Amyloid Aggregation Via BSA@FGQDs Multimodal Probe.

An environmentally sensitive molecular rotor as a NIR fluorescent probe for the detection of islet amyloid polypeptide

Inhibition of insulin fibrillation by osmolytes: Mechanistic Insights

A Redox Cycle Meets Insulin Fibrillation in Vitro.

An Achilles' Heel in an Amyloidogenic Protein and Its Repair: INSULIN FIBRILLATION AND THERAPEUTIC DESIGN

Effect of 33 Hz Pulsed Electric Field on Insulin Amyloidosis